Search results
Results From The WOW.Com Content Network
The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [ 7][ 8]
The vaccines are the first approved to prevent RSV, which causes around 14,000 deaths in adults aged 65 and older in the U.S. annually, according to government estimates. US CDC OKs use of new ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
In April, Pfizer said its vaccine succeeded in a trial evaluating it in adults under age 60, adding that it plans to submit for expanded approval of the vaccine in adults aged 18 to 59. GSK also ...
GSK, one of the world's largest vaccine manufacturers, will take control of CureVac's leading experimental vaccines to fight infections, including seasonal flu and bird flu. It will pay CureVac ...
Fendrix (hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)) Fluarix (trivalent) & Fluarix (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) FluLaval (trivalent) & FluLaval (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) Havrix (for hepatitis A vaccine, inactivated) Hepatyrix (for hepatitis A (inactivated ...
GSK said Pfizer's vaccine infringes four of its patents related to the antigen its shots use to fight the respiratory disease. Pfizer and GSK are running a tight race to tap into the RSV vaccine ...
GSK plc (76.5%) Pfizer (13.5%) Shionogi (10%) Number of employees. c. 1,100 (2023) Website. viivhealthcare .com. ViiV Healthcare ( / ˈviːv / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent HIV/AIDS. Its global headquarters is located in London.